Skip to content
DraconiticResearch
Search Sources API
220,620 studies31 sourcesUpdated 41 min ago

Oncology

5,780 studies504 in 7 days2,684 in 30 days

Filters
Type
Date
Clear

Latest

5,780 studies

  1. Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
    Haoyue Liu, Jeong-Hoon Jang, Fuduan Peng +29
    Cancer DiscoveryPeer-reviewedCC BY-NC-ND 4.0Full text1 citedOncologyPMC
  2. The mechanism of NaB-activated lytic replication of EBV and its hub genes in transcriptome regulation of gastric cancer cells
    Yuying Chen, Zhaoxin Tian, Zhiyuan Gong +2
    VirusDiseasePeer-reviewedLicence not statedFull text1 citedOncologyPMC
  3. Thermodynamic Quality Control Reshapes Spatially Resolved Metabolic Flux Predictions in Prostate Cancer
    Mohammad Reza Zargar, Sunayana Malla, Rajib Saha +1
    bioRxivPreprintCC BYFull textOncologybioRxivPMC
  4. Extravascular coagulation stabilizes pro-fibrotic stromal states via tumor-intrinsic PAR1 signaling in pancreatic ductal adenocarcinoma
    S. R. Choi, N. O. Munoz, H.-r. Moon +12
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  5. Targeting Isocitrate Dehydrogenase-Mutant Glioma with Vorasidenib : A New Era in Precision Neuro-Oncology
    Kyung-Min Kim, Yukyeng Byeon, Chaejin Lee +9
    Journal of Korean Neurosurgical SocietyPeer-reviewedCC BY-NC 4.0Full text1 citedOncologyPMC
  6. Benefits and adverse events of combined chemotherapy and immune checkpoint inhibition in non-metastatic triple-negative breast cancer: a systematic review and an updated meta-analysis
    Jianmin Wu, Kejing Zhang
    Translational Breast Cancer ResearchPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  7. An integrated structural and functional profiling approach uncovers the mechanisms of pregnane X receptor binding and activation by pharmaceutical and environmental compounds
    Quentin Derosa, Coralie Carivenc, Savannah Sirounian +5
    Molecular PharmacologyPeer-reviewedCC BY 4.0Full textOncologyHALPMC
  8. Modeling, Analysis, and Optimal Control of Leukemic Cell Population Dynamics Under Therapy
    Pauline Mazel, Frédéric Grognard, Thomas Stiehl +2
    Bulletin of Mathematical BiologyPeer-reviewedCC BY 4.0Full textOncologyHAL
  9. Psychological consequences of functional sequelae after rectal cancer treatment: a narrative review
    Nicolas Michot, Eugenie Roussel, Urs Giger-Pabst +4
    Discover PsychologyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyHAL
  10. LncRNA Gas5 directs SUV39H2 to establish heterochromatin and maintain genome stability
    Juntao Liu, Jiani Yang, Wen Ye +6
    Protein & CellPeer-reviewedCC BY 4.0Full textOncologyPMC
  11. Recent progress in cancer multidrug resistance and therapeutic options associated with protein damage response
    Fangyuan Shao, Dongyang Tang, Ling Li +2
    Protein & CellPeer-reviewedCC BY 4.0Full textOncologyPMC
  12. PANTHER Challenge Report: Cross-Domain Pancreatic Tumor Segmentation in Magnetic Resonance Imaging
    Amparo Betancourt Tarifa, Marcel Verheij, René Monshouwer +21
    Medical Image AnalysisPeer-reviewedCC BY 4.0Full textOncologyHAL
  13. BAYESIAN SELECTION AND REFITTING OF REFERENCE MUTATIONAL SIGNATURES IN CANCER GENOMICS
    Min Hua, Bin Zhu
    The annals of applied statisticsPeer-reviewedLicence not statedFull textOncologyPMC
  14. Successful palliative hypofractionated radiotherapy with superficial hyperthermia for heavily pretreated cutaneous breast cancer lesions
    D. M. V. de Vries-Huizing, A. Holtmaat, M. W. Kolff +1
    Strahlentherapie Und OnkologiePeer-reviewedCC BY 4.0Full textOncologyPMC
  15. Combined Diagnostic Utility of Serum CA15-3 and Routine Hematological Indicators for Breast Cancer Differentiation in an Iraqi Cohort
    Mohammed Jaber Mohaibes, Mayada Al-Khafaji, Fakhria Muhaibes
    Asian Pacific Journal of Cancer Prevention : APJCPPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  16. Temporal Hematologic Alterations in Women Receiving Pharmacotherapy for Breast Cancer: A Prospective Analysis
    Henry Sutanto, Merlyna Savitri, Ami Ashariati +5
    Asian Pacific Journal of Cancer Prevention : APJCPPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  17. Rapid Psychosocial Screening Instruments for Cancer Patients: A Scoping Review of Measurement Tools and Psychometric Evidence
    Ida Maryati, Raini Diah Susanti, Taty Hernawaty +5
    Asian Pacific Journal of Cancer Prevention : APJCPPeer-reviewedCC BY-NC 4.0Full text1 citedOncologyPMC
  18. Medically Supervised Exercise and Inflammation in Breast Cancer Survivors with Metabolic Syndrome: A Meta-Analysis
    Jean Paul Muambangu Milambo
    Asian Pacific Journal of Cancer Prevention : APJCPPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  19. Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance
    Guang Lei, Zhengze Lu, Zhihao Xu +33
    CellPeer-reviewedCC BYFull text23 citedOncologyOpenAlexPMC
  20. Prognostic and Clinical Significance of Circulating Cystatin C Levels in Cancer Patients: A Meta-Analysis
    Sehreen Tory, Md. Mojahidur Hasan, Yusuf Kemal Arslan +2
    Asian Pacific Journal of Cancer Prevention : APJCPPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  21. Blood-Based vs. Tissue-Based mRNA Expression of Thymidylate Synthase, Dihydropyrimidine Dehydrogenase, and Methylenetetrahydrofolate Reductase: A Prospective Study to Predict the Neoadjuvant CAPEOX Response in Advanced Colorectal Cancer
    Elvida Christi Imelda Tahiya, Ronald Erasio Lusikooy, Ilhamjaya Patelongi +7
    Asian Pacific Journal of Cancer Prevention : APJCPPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  22. The prognostic value of tumour budding for survival in stage II and III colorectal cancer: a systematic review and meta‐analysis
    Yao Shu, Heng Zhang, Alessandro Lugli +2
    HistopathologyPeer-reviewedCC BY-NC-ND 4.0Full text3 citedOncologyPMC
  23. Sodium Butyrate Activity in Colorectal Cancer under Hypoxia: A Potential Role for Carbonic Anhydrase IX
    Haifa Alayssami, Mahmood Y Hachim, Abiola Senok +1
    Asian Pacific Journal of Cancer Prevention : APJCPPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  24. Glucocorticoid and mitophagy signaling–based molecular subtyping reveals HMGA1 as a prognostic and immunotherapy biomarker in lung adenocarcinoma
    Junjie Yu, Yantao Jiang, Qingqing Xiong +7
    NPJ Precision OncologyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  25. Glycolytic reprogramming in cancer: tumour cell metabolism, immune modulation, and therapeutic opportunities
    Lei Wang, Fangfang Liu, Yuxuan Wei +3
    Journal of Translational MedicinePeer-reviewedCC BY-NC-ND 4.0Full text1 citedOncologyPMC